Literature DB >> 28610892

Novel human neuronal tau model exhibiting neurofibrillary tangles and transcellular propagation.

Patrick Reilly1, Charisse N Winston1, Kelsey R Baron1, Margarita Trejo2, Edward M Rockenstein1, Johnny C Akers3, Najla Kfoury4, Marc Diamond4, Eliezer Masliah2, Robert A Rissman5, Shauna H Yuan6.   

Abstract

Tauopathies are a class of neurodegenerative diseases, including Alzheimer's disease, frontotemporal dementia and progressive supranuclear palsy, which are associated with the pathological aggregation of tau protein into neurofibrillary tangles (NFT). Studies have characterized tau as a "prion-like" protein given its ability to form distinct, stable amyloid conformations capable of transcellular and multigenerational propagation in clonal fashion. It has been proposed that progression of tauopathy could be due to the prion-like propagation of tau, suggesting the possibility that end-stage pathologies, like NFT formation, may require an instigating event such as tau seeding. To investigate this, we applied a novel human induced pluripotent stem cell (hiPSC) system we have developed to serve as a human neuronal model. We introduced the tau repeat domain (tau-RD) with P301L and V337M (tau-RD-LM) mutations into hiPSC-derived neurons and observed expression of tau-RD at levels similar to total tau in postmortem AD brains. Tau aggregation occurred without the addition of recombinant tau fibrils. The conditioned media from tau-RD cultures contained tau-RD seeds, which were capable of inducing aggregate formation in homotypic mode in non-transduced recipient neuronal cultures. The resultant NFTs were thioflavin-positive, silver stain-positive, and assumed fibrillary appearance on transmission electron microscopy (TEM) with immunogold, which revealed paired helical filament 1 (PHF1)-positive NFTs, representing possible recruitment of endogenous tau in the aggregates. Functionally, expression of tau-RD caused neurotoxicity that manifested as axon retraction, synaptic density reduction, and enlargement of lysosomes. The results of our hiPSC study were reinforced by the observation that Tau-RD-LM is excreted in exosomes, which mediated the transfer of human tau to wild-type mouse neurons in vivo. Our hiPSC human neuronal system provides a model for further studies of tau aggregation and pathology as well as a means to study transcellular propagation and related neurodegenerative mechanisms.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Exosomes; Induced pluripotent stem cells; Neurofibrillary tangles; Propagation; Tau

Mesh:

Substances:

Year:  2017        PMID: 28610892      PMCID: PMC5593133          DOI: 10.1016/j.nbd.2017.06.005

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  55 in total

1.  Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau.

Authors:  G A Jicha; R Bowser; I G Kazam; P Davies
Journal:  J Neurosci Res       Date:  1997-04-15       Impact factor: 4.164

2.  Development of a Scalable, High-Throughput-Compatible Assay to Detect Tau Aggregates Using iPSC-Derived Cortical Neurons Maintained in a Three-Dimensional Culture Format.

Authors:  X Medda; L Mertens; S Versweyveld; A Diels; L Barnham; A Bretteville; A Buist; A Verheyen; I Royaux; A Ebneth; A Cabrera-Socorro
Journal:  J Biomol Screen       Date:  2016-03-16

3.  Transgenic mouse model of tauopathies with glial pathology and nervous system degeneration.

Authors:  Makoto Higuchi; Takeshi Ishihara; Bin Zhang; Ming Hong; Athena Andreadis; John Trojanowski; Virginia M-Y Lee
Journal:  Neuron       Date:  2002-08-01       Impact factor: 17.173

4.  Brain injury biomarkers are not dependent on β-amyloid in normal elderly.

Authors:  David S Knopman; Clifford R Jack; Heather J Wiste; Stephen D Weigand; Prashanthi Vemuri; Val J Lowe; Kejal Kantarci; Jeffrey L Gunter; Matthew L Senjem; Michelle M Mielke; Rosebud O Roberts; Bradley F Boeve; Ronald C Petersen
Journal:  Ann Neurol       Date:  2013-02-19       Impact factor: 10.422

Review 5.  Mechanisms of tau-induced neurodegeneration.

Authors:  Khalid Iqbal; Fei Liu; Cheng-Xin Gong; Alejandra Del C Alonso; Inge Grundke-Iqbal
Journal:  Acta Neuropathol       Date:  2009-01-30       Impact factor: 17.088

6.  Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells.

Authors:  Hadi Valadi; Karin Ekström; Apostolos Bossios; Margareta Sjöstrand; James J Lee; Jan O Lötvall
Journal:  Nat Cell Biol       Date:  2007-05-07       Impact factor: 28.824

7.  Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology.

Authors:  Robert A Rissman; Wayne W Poon; Mathew Blurton-Jones; Salvatore Oddo; Reidun Torp; Michael P Vitek; Frank M LaFerla; Troy T Rohn; Carl W Cotman
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

8.  Distinct tau prion strains propagate in cells and mice and define different tauopathies.

Authors:  David W Sanders; Sarah K Kaufman; Sarah L DeVos; Apurwa M Sharma; Hilda Mirbaha; Aimin Li; Scarlett J Barker; Alex C Foley; Julian R Thorpe; Louise C Serpell; Timothy M Miller; Lea T Grinberg; William W Seeley; Marc I Diamond
Journal:  Neuron       Date:  2014-05-22       Impact factor: 17.173

Review 9.  Extracellular vesicles: exosomes, microvesicles, and friends.

Authors:  Graça Raposo; Willem Stoorvogel
Journal:  J Cell Biol       Date:  2013-02-18       Impact factor: 10.539

10.  Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells.

Authors:  Mason A Israel; Shauna H Yuan; Cedric Bardy; Sol M Reyna; Yangling Mu; Cheryl Herrera; Michael P Hefferan; Sebastiaan Van Gorp; Kristopher L Nazor; Francesca S Boscolo; Christian T Carson; Louise C Laurent; Martin Marsala; Fred H Gage; Anne M Remes; Edward H Koo; Lawrence S B Goldstein
Journal:  Nature       Date:  2012-01-25       Impact factor: 49.962

View more
  22 in total

1.  Tauopathy-associated PERK alleles are functional hypomorphs that increase neuronal vulnerability to ER stress.

Authors:  Shauna H Yuan; Nobuhiko Hiramatsu; Qing Liu; Xuehan Victoria Sun; David Lenh; Priscilla Chan; Karen Chiang; Edward H Koo; Aimee W Kao; Irene Litvan; Jonathan H Lin
Journal:  Hum Mol Genet       Date:  2018-11-15       Impact factor: 6.150

2.  Protein Biomarkers and Neuroproteomics Characterization of Microvesicles/Exosomes from Human Cerebrospinal Fluid Following Traumatic Brain Injury.

Authors:  Rachna Manek; Ahmed Moghieb; Zhihui Yang; Dhwani Kumar; Firas Kobessiy; George Anis Sarkis; Vijaya Raghavan; Kevin K W Wang
Journal:  Mol Neurobiol       Date:  2017-11-29       Impact factor: 5.590

3.  Detection of Alzheimer Disease (AD)-Specific Tau Pathology in AD and NonAD Tauopathies by Immunohistochemistry With Novel Conformation-Selective Tau Antibodies.

Authors:  Garrett S Gibbons; Rachel A Banks; Bumjin Kim; Lakshmi Changolkar; Dawn M Riddle; Susan N Leight; David J Irwin; John Q Trojanowski; Virginia M Y Lee
Journal:  J Neuropathol Exp Neurol       Date:  2018-03-01       Impact factor: 3.685

Review 4.  Current and future applications of induced pluripotent stem cell-based models to study pathological proteins in neurodegenerative disorders.

Authors:  Aurélie de Rus Jacquet; Hélèna L Denis; Francesca Cicchetti; Melanie Alpaugh
Journal:  Mol Psychiatry       Date:  2021-01-25       Impact factor: 13.437

5.  Detection of Aggregation-Competent Tau in Neuron-Derived Extracellular Vesicles.

Authors:  Francesc X Guix; Grant T Corbett; Diana J Cha; Maja Mustapic; Wen Liu; David Mengel; Zhicheng Chen; Elena Aikawa; Tracy Young-Pearse; Dimitrios Kapogiannis; Dennis J Selkoe; Dominic M Walsh
Journal:  Int J Mol Sci       Date:  2018-02-27       Impact factor: 5.923

Review 6.  Challenges for Alzheimer's Disease Therapy: Insights from Novel Mechanisms Beyond Memory Defects.

Authors:  Rudimar L Frozza; Mychael V Lourenco; Fernanda G De Felice
Journal:  Front Neurosci       Date:  2018-02-06       Impact factor: 4.677

7.  Calpain-mediated tau fragmentation is altered in Alzheimer's disease progression.

Authors:  Hsu-Hsin Chen; Peter Liu; Paul Auger; Seung-Hye Lee; Oskar Adolfsson; Lorianne Rey-Bellet; Julien Lafrance-Vanasse; Brad A Friedman; Maria Pihlgren; Andreas Muhs; Andrea Pfeifer; James Ernst; Gai Ayalon; Kristin R Wildsmith; Thomas G Beach; Marcel P van der Brug
Journal:  Sci Rep       Date:  2018-11-13       Impact factor: 4.379

8.  Assessing Neuronal and Astrocyte Derived Exosomes From Individuals With Mild Traumatic Brain Injury for Markers of Neurodegeneration and Cytotoxic Activity.

Authors:  Charisse N Winston; Haylie K Romero; Maya Ellisman; Sophie Nauss; David A Julovich; Tori Conger; James R Hall; Wendy Campana; Sid E O'Bryant; Caroline M Nievergelt; Dewleen G Baker; Victoria B Risbrough; Robert A Rissman
Journal:  Front Neurosci       Date:  2019-10-02       Impact factor: 4.677

9.  Mutant Presenilin 1 Dysregulates Exosomal Proteome Cargo Produced by Human-Induced Pluripotent Stem Cell Neurons.

Authors:  Sonia Podvin; Alexander Jones; Qing Liu; Brent Aulston; Charles Mosier; Janneca Ames; Charisse Winston; Christopher B Lietz; Zhenze Jiang; Anthony J O'Donoghue; Tsuneya Ikezu; Robert A Rissman; Shauna H Yuan; Vivian Hook
Journal:  ACS Omega       Date:  2021-05-13

Review 10.  Mechanisms of secretion and spreading of pathological tau protein.

Authors:  Cecilia A Brunello; Maria Merezhko; Riikka-Liisa Uronen; Henri J Huttunen
Journal:  Cell Mol Life Sci       Date:  2019-10-30       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.